Participated · Equity · Apr 2021

Supersapiens builds an ecosystem that integrates with the Abbott Libre Sense Glucose Sport Biosensor to give athletes real-time glucose data tied to athletic performance. The company focuses on energy management systems to help athletes sustain high-intensity work, manage glucose for recovery, and improve performance gains. Its product set currently centers on software and integrations with Bluetooth-enabled CGM sensors, and the company is developing its first hardware wrist wearable, the Supersapiens Reader Version Zero, to display live fuel data. In its first 12 weeks on the market the company enrolled more than 2,000 paying athletes on the system. The Abbott Libre Sense biosensor used in the ecosystem is intended for athletes and is not intended for diagnosis, treatment, or monitoring of disease. The service is available across several European markets including Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland and the United Kingdom; it is not yet for sale in the U.S.

Participated · Seed · Feb 2021

Jack & Bry produces a range of jackfruit meat alternatives, including burgers, mince, sausages and a pepperoni pizza ingredient, using a proprietary manufacturing process. The company intends to use the seed funding to further product innovation and develop more jackfruit products that closely mimic the texture of meat. Founded in 2019 by CEO Bryony Tinn-Disbury and joined by Chief Operations Officer Jennifer Pardoe, the company recently launched a Fillet-no-Fish plant-based fast food fish burger at Neat Burger. Jack & Bry already supplies 138 Zizzi sites, 450 Papa John’s outlets in the UK and Netherlands and 300 Sainsbury’s stores, with products set to launch in The Vegan Kind and Central Foods. The company has added FMCG industry veterans to its management team, including former Quorn chairman Clive Sharpe and Singha Europe MD David Flower.